NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
female and male adult patients with acute myeloid leukemia (AML) at first or second relapse after
intensive chemotherapy including allogeneic stem cell transplantation or primary
refractory to standard induction chemotherapy who are eligible for intensive
salvage treatment
1 total trials
Filter these 1 trials by phase, country, sponsor and more.